Case File
efta-efta01800530DOJ Data Set 10CorrespondenceEFTA Document EFTA01800530
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01800530
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Paul S Barrett <
Sent:
Thursday, December 9, 2010 2:31 PM
To:
Jeffrey Epstein
Subject:
RE: A few things
OK=o:p>
Also have the 1st leg of our =il options coming off next week
=span style=lont-size:11.0ptfont-fam ily:"Cal ibri","sans-serif";color:=1F49705
&nb=p;
<=p>
Paul Barrett, CFA
M=naging Director
Global Investment Opp=rtunities Group
JPMorgan Private Bank=o:p>
40W 57th Street, 33rd Floor, New York= NY 10019
(W) =
(F)
From: Jeffrey Epstein (mailto:[email protected]
Sent: Thursday, December 09, 2010 9:20 AM Paul S Barrett
Subject: Re: A few things
in an hour
On Thu, Dec 9, 2010 at 9:18 AM, Paul S Barrett
Jeffrey
=gt; wrote:
<=>From: Paul S Barrett
Sent: Monday, December 06, 2010 12:=7 PM
To: 'Epstein, Jeffrey ([email protected] <mailto:jeevacation@gmail=2Ecom> )'
EFTA_R1_00140166
EFTA01800530
Subject: = few things
=/span>Switching our GM bond exposure in=o the convert
le=t you a message.
Paul
&nbs=;
<=:p>
Paul Barrett, CFA
Managing Dire=tor
Global Investment Opportunities Group
1PMorgan Private Bank
40W 57th Street,=33rd Floor, New York, NY 10019
(W)&nbs=;
(F)
<mailto
</=iv>
This email is confident=al and subject to important disclaimers and conditions including on offers=for the purchase or
sale of securities, accuracy and completeness of infor=ation, viruses, confidentiality, legal privilege, and legal entity
disclai=ers, available at http://www.jpmorgan.com/pages/disclosures/ema=l
chttp://www.jpmorgan.com/pages/disdosures=email> .
=r>The information contained in this
communication is confidential, may =e attorney-client privileged, may constitute inside information, and is=intended
only for the use of the addressee. It is the property of =effrey Epstein Unauthorized use, disclosure or copying of this
comm=nication or any part thereof is strictly prohibited and may be unlawful=2E If you have received this
communication in error, please notify us i=mediately by return e-mail or by e-mail to [email protected]
<mailto:[email protected]> , and destroy this communicati=n and all copies thereof, including all attachments.
2
EFTA_R1_00140167
EFTA01800531
</=iv>
This email is confidential and subject to important disclaim=rs and conditions including on offers for the purchase or sale
of securiti=s, accuracy and completeness of information, viruses, confidentiality, leg=l privilege, and legal entity
disclaimers, available at http://www.jpmor=an.com/pages/disclosures/email.
3
EFTA_R1_00140168
EFTA01800532
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]URL
http://www.jpmor=an.com/pages/disclosures/emailURL
http://www.jpmorgan.com/pages/disclosures/ema=lRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.